224 related articles for article (PubMed ID: 21349347)
1. Does process excellence handcuff drug development?
Koenig J
Drug Discov Today; 2011 May; 16(9-10):377-81. PubMed ID: 21349347
[TBL] [Abstract][Full Text] [Related]
2. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
Betz UA
Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
[TBL] [Abstract][Full Text] [Related]
3. Can open-source drug R&D repower pharmaceutical innovation?
Munos B
Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
[TBL] [Abstract][Full Text] [Related]
4. A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness.
Refoios Camejo R; McGrath C; Herings R
Health Policy; 2011 Apr; 100(1):18-24. PubMed ID: 20864202
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical research and development.
McKercher PL
Clin Ther; 1992; 14(5):760-4; discussion 759. PubMed ID: 1468093
[TBL] [Abstract][Full Text] [Related]
6. What is the most important approach in current drug discovery: doing the right things or doing things right?
Elebring T; Gill A; Plowright AT
Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from candidate drug attrition.
Empfield JR; Leeson PD
IDrugs; 2010 Dec; 13(12):869-73. PubMed ID: 21154145
[TBL] [Abstract][Full Text] [Related]
8. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
9. R&D transformation and value-based innovation.
Epstein RS
J Comp Eff Res; 2012 Jan; 1(1 Suppl):1-2. PubMed ID: 24237315
[No Abstract] [Full Text] [Related]
10. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
11. Impact of economic, regulatory, and patent policies on innovation in cancer chemoprevention.
Grabowski HG; Moe JL
Cancer Prev Res (Phila); 2008 Jul; 1(2):84-90. PubMed ID: 19138940
[TBL] [Abstract][Full Text] [Related]
12. Discontinued drugs in 2010: oncology drugs.
Williams R
Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
[TBL] [Abstract][Full Text] [Related]
13. The seven types of drug discovery waste: toward a new lean for the drug industry.
Uitdehaag JC
Drug Discov Today; 2011 May; 16(9-10):369-71. PubMed ID: 21354473
[No Abstract] [Full Text] [Related]
14. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
Aksu B; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; de Matas M; Oostra W; Rantanen J; Weimer M
Eur J Pharm Sci; 2012 Sep; 47(2):402-5. PubMed ID: 22749874
[TBL] [Abstract][Full Text] [Related]
15. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
17. The value of drug repositioning in the current pharmaceutical market.
Tobinick EL
Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
[TBL] [Abstract][Full Text] [Related]
18. Developing pharmacogenetic evidence throughout clinical development.
Burns DK
Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
[TBL] [Abstract][Full Text] [Related]
19. An assessment of R&D productivity in the pharmaceutical industry.
Dimitri N
Trends Pharmacol Sci; 2011 Dec; 32(12):683-5. PubMed ID: 22030299
[TBL] [Abstract][Full Text] [Related]
20. Innovation leading the way: application of lean manufacturing to sample management.
Allen M; Wigglesworth MJ
J Biomol Screen; 2009 Jun; 14(5):515-22. PubMed ID: 19483142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
